RT-PCR analysis showed that the mRNA levels of Bv8, S100a8, S100a9, and Mmp9 were significantly higher in the lungs of tumor-bearing mice after 2 weeks of sunitinib treatment than those in tumor-bearing control mice (Fig. 7a). The gene discussed is MMP9; the disease is neoplasm.